RTGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
RetinalGenix Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.99+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $75.04M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
RetinalGenix Technologies has not reported a dividend
No dividend per share appears in RetinalGenix Technologies's annual filings since fiscal 2019.